Veradigm Inc. (MDRX)
OTCMKTS
· Delayed Price · Currency is USD
9.45
0.00 (0.00%)
Dec 27, 2024, 4:00 PM EST
Veradigm Revenue
Veradigm had revenue of $151.92M in the quarter ending September 30, 2022, with 5.01% growth. This brings the company's revenue in the last twelve months to $1.53B, up 89.72% year-over-year. In the year 2021, Veradigm had annual revenue of $1.50B with 0.02% growth.
Revenue (ttm)
1.53B
Revenue Growth
+89.72%
P/S Ratio
0.71
Revenue / Employee
191.13K
Employees
8,000
Market Cap
1.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 1.50B | 337.00K | 0.02% |
Dec 31, 2020 | 1.50B | -129.91M | -7.96% |
Dec 31, 2019 | 1.63B | 14.77M | 0.91% |
Dec 31, 2018 | 1.62B | 120.13M | 8.02% |
Dec 31, 2017 | 1.50B | 111.64M | 8.05% |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 16.04M |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 21.77M |
Jun An Kang Group | 4.47M |
BioStem Technologies | 210.49M |
SANUWAVE Health | 29.30M |
Veradigm News
- 18 days ago - Glancy Prongay & Murray LLP Announces Investigation of Veradigm Inc. (MDRX) - Business Wire
- 25 days ago - Veradigm Inc (MDRX) Stock Surges Amidst Financial Report Insights - GuruFocus
- 5 weeks ago - Veradigm Launches an Ambient Scribe Advancement to Ease the Healthcare Administrative Burden - Business Wire
- 5 weeks ago - Veradigm Advancing Point of Care Engagement Through Payer-Provider Collaboration - Business Wire
- 6 weeks ago - Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy + - Seeking Alpha
- 6 weeks ago - Veradigm And The 2025 M&A Boom - Seeking Alpha
- 2 months ago - Veradigm Advances Deeper Clinical Insights Through NLP-Enhanced EHR Data - Business Wire
- 3 months ago - Automated Medical Chart Retrieval Expands to 300,000+ U.S. Healthcare Providers via Veradigm eChart Courier - Business Wire